These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9371930)

  • 1. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.
    Optic Neuritis Study Group
    Neurology; 1997 Nov; 49(5):1404-13. PubMed ID: 9371930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
    Lai C; Chang Q; Tian G; Wang J; Yin H; Liu W
    PLoS One; 2015; 10(10):e0141005. PubMed ID: 26485719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
    Swanton JK; Fernando KT; Dalton CM; Miszkiel KA; Altmann DR; Plant GT; Thompson AJ; Miller DH
    Mult Scler; 2010 Feb; 16(2):156-65. PubMed ID: 20086028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.
    Optic Neuritis Study Group
    Arch Neurol; 2008 Jun; 65(6):727-32. PubMed ID: 18541792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial.
    Rolak LA; Beck RW; Paty DW; Tourtellotte WW; Whitaker JN; Rudick RA
    Neurology; 1996 Feb; 46(2):368-72. PubMed ID: 8614496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting multiple sclerosis at optic neuritis onset.
    Jin YP; de Pedro-Cuesta J; Huang YH; Söderström M
    Mult Scler; 2003 Mar; 9(2):135-41. PubMed ID: 12708808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of prognostic biomarkers in optic neuritis.
    Tejeda-Velarde A; Costa-Frossard L; Sainz de la Maza S; Carrasco Á; Espiño M; Picón C; Toboso I; Walo PE; Lourido D; Muriel A; Álvarez-Cermeño JC; Villar LM
    Eur J Neurol; 2018 Apr; 25(4):614-618. PubMed ID: 29272057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute demyelinating optic neuritis.
    Balcer LJ; Galetta SL
    Semin Ophthalmol; 2002 Mar; 17(1):4-10. PubMed ID: 15513449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.
    Beck RW; Kupersmith MJ; Cleary PA; Katz B
    Ophthalmology; 1993 May; 100(5):691-7; discussion 697-8. PubMed ID: 8493012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
    Marques IB; Matias F; Silva ED; Cunha L; Sousa L
    J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving management of optic neuritis and multiple sclerosis.
    Arnold AC
    Am J Ophthalmol; 2005 Jun; 139(6):1101-8. PubMed ID: 15953446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group.
    Cole SR; Beck RW; Moke PS; Kaufman DI; Tourtellotte WW
    Neurology; 1998 Sep; 51(3):885-7. PubMed ID: 9748050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: value of baseline results to predict the development of new lesions at one year follow up.
    Frederiksen JL; Petrera J; Larsson HB; Stigsby B; Olesen J
    Acta Neurol Scand; 1996 Apr; 93(4):246-52. PubMed ID: 8739433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of idiopathic optic neuritis.
    Ghezzi A; Martinelli V; Rodegher M; Zaffaroni M; Comi G
    Neurol Sci; 2000; 21(4 Suppl 2):S865-9. PubMed ID: 11205365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA typing in acute optic neuritis. Relation to multiple sclerosis and magnetic resonance imaging findings.
    Frederiksen JL; Madsen HO; Ryder LP; Larsson HB; Morling N; Svejgaard A
    Arch Neurol; 1997 Jan; 54(1):76-80. PubMed ID: 9006417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests.
    Ghezzi A; Martinelli V; Torri V; Zaffaroni M; Rodegher M; Comi G; Zibetti A; Canal N
    J Neurol; 1999 Sep; 246(9):770-5. PubMed ID: 10525973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial.
    Luo W; Deng X; Xu X; Song R; Luo M; Moss HE; Du Y
    J Neuroophthalmol; 2022 Mar; 42(1):88-96. PubMed ID: 34860745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.